{"name":"Allegro Ophthalmics, LLC","slug":"allegro-ophthalmics-llc","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMiywJBVV95cUxNal9yb0poS19QYmQ1U3N3bGFzYXJ3VVFoNFZ1bFBEbWFTRGIwbmZOcVdqR0JaSWtsNjR1dVhjNzRaVFJLUzJBSDQtRUpha1VkNW9WSDdlY3pOd2FHeTRHXzhtUEZwMlJYSWFoWUhucWQ1eWdtTEkxNzR1MHlrSGpvUnBkZVE0ODlWQVpoRWhBS19iSUlXY3FsemVFd0xzV2RmOV91MUxSZ2NoWTFnNjFqQXF1QW83YzRTNDZlZ0FNYmZha1dGRjVNbzViMldQSXdyRXl6V1EtVmdRYlZOZHZuTnVQU2ZZR1NZQ0hqRmpuZkw1X09uRHMzd0duNlpOZlhULWMzRnVlajBBb3g0OWJYQnExeGNMc2ZqZHFuMld5YmFObkVMZFF0VXJLT3BpRVRFM3ZUS2Q4TGw4TDhLUUhGS1V4VU1kbS00Q0NR?oc=5","date":"2025-12-01","type":"pipeline","source":"GlobeNewswire","summary":"Geographic Atrophy Market to Surge Significantly During the - GlobeNewswire","headline":"Geographic Atrophy Market to Surge Significantly During the","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMixwJBVV95cUxQdjA4NjRPMVVoaVhDdmI1M2tpb0pyWlNpd3hTLVRNT01zNXVJc3NPQUpnUUEyV1pqZWNUN2lXdFdDX3dkcUNuTklNWU9NMzNQWGFXcGtRNF94QW5BTkhnYTBqN25OTmpBUVB4YXZTalg5UnN3TkNKZTdqa0ZyM2Njc21EX1MtQ0F6Y19pVHlNeXM0R21OV3dKaU01aHNOSzRBcV9CWWlmNFlHS25hQ3R5S1VKRjQyRmZWOWE2UHNRclJEakY4X1ZLekEtNmViMkFpclRzaldDT1RVaHBoanhNbUJBVG41NUxtTE1XUGxfa3JaZXQwUW54enQ1cFN3NmtwUTJHUlR0c0tHWHRLTDFKSlNuSnlEaUNRa2JqYXk5aGZKQTdOaTk0YTVyUnpKaHRiNDQwNmJkUFFJS2dhckhpN3BxNVkzRjg?oc=5","date":"2025-11-17","type":"pipeline","source":"GlobeNewswire","summary":"Dry Age-related Macular Degeneration Market Poised for - GlobeNewswire","headline":"Dry Age-related Macular Degeneration Market Poised for","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMihgJBVV95cUxPVnJhTFdRMWtFd05PME5YVmJTREdROGZkOTF2WlR0UUJvSy10QWowRUNqZXNmR183Nkp6WkFfVDZ2UHBJdXZKYzVBM2dDUG50U01SdGxhTE4yODk2Y1daQzNoTWtGclczZzEybWRrTDB3LU02TDN4TVQ4QjJhNkRPWXo1N3dob0RldDVUNzEwOU1RcWRlZl90SkVsNGlkMHhHT1pmN1IzTElBOUtNQWxDUXVXVHFfRFI2WmdKTEk2RjZ5WW1FU0pwcmdwV3Y4UGdKZjFDVmV4aEZWUkY4VDBfOHpyVTZabU5FWi1fVWhMVzVBQlU1OWxjd0xoRmVRT1ltX01Sbldn?oc=5","date":"2025-06-16","type":"pipeline","source":"GlobeNewswire","summary":"Comprehensive Age-related Macular Degeneration Market Analysis: Trends and Developments Across All Types - GlobeNewswire","headline":"Comprehensive Age-related Macular Degeneration Market Analysis: Trends and Developments Across All Types","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMipgJBVV95cUxOUGZDWHYtTnJZUFI0dHVqOVFMMmhBeWxuWkdyamtDWkxOcVhpeF80V1JnRFMwNFBHLXk1dUFhNzg2WnJTOUg1VllZcktmSll3X3JkdWpmSTZjX1dNY0xfMFhtMFRSRk1ITFJKbDRtU1NYUlZVaFdXblFXdkFub2pvejdwTG9kWUF4czd0Mlp5YVRPVlFkVU1HU2FuSGpjUzl4aGhGcFVRR3ZHaE4xR0tpTG9OdXR4WXdpZWgwTjFTeWFySDRJenhtTHZ6RjZIRnlPeEZWb01sSkltNmdMcHE0eUltNGtuSnhrM3IwTlI3S1hXQXU3UzNrWjJoekhHVXJPRjkxRlI4Y3lGSG5VWVRGcjk0bTN3NC1QdFBDOEhHRk1jWmc4bGc?oc=5","date":"2023-04-13","type":"regulatory","source":"Ophthalmology Times","summary":"Allegro Ophthalmics receives FDA agreement under Special Protocol Assessment for Phase 2b/3 clinical trial of risuteganib for treatment of intermediate dry AMD - Ophthalmology Times","headline":"Allegro Ophthalmics receives FDA agreement under Special Protocol Assessment for Phase 2b/3 clinical trial of risutegani","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiyAFBVV95cUxOcnI1VEtFU09BczNwbWFqUlFzWjAzTkhCTGFYVl9aVEVNdFpXbHBXTU9xRU90QUNEMmhfM1p5RVpmbDloZFNjRW1VUVd3Q3ExMnhFMmNtWlVHdjZ5eUNJMzVVZFEyRDlyeDkwNU40REpSN0llWUFaWDduWlJJZkhoTWRUR0VqZTJSbkpKT05NbDJjWXNMQ0NwYnp5LUxpdVBXYU1FWjBmY2wtVFhDSVdlemMwSFhzMHBXa1J2QVBTY0cwR3ZYZkM0MQ?oc=5","date":"2023-04-12","type":"regulatory","source":"Eyes On Eyecare","summary":"Allegro Ophthalmics earns FDA approval for intermediate dry AMD trial design - Eyes On Eyecare","headline":"Allegro Ophthalmics earns FDA approval for intermediate dry AMD trial design","sentiment":"positive"},{"url":"https://news.google.com/rss/articles/CBMiogJBVV95cUxQWmY3c2FlbGhpRUJQWWh3MzdROVlPMEN2TlVEWHY1WGJ0MjM3Z3ZTMWRRNGJRZGw4VDdteDZlWDVHZENHUkp5N1BMZ0doN0FUQ3ItbEk2X0ZOYjhIczBSZ3JzODlDckFXQWR5MmktMUhWWTU0WTRGQlNaN2NBcmg2eE9taU5KZFFRcFpoMFRPUldTRVA1bER1NFNlUF9USjVQQVVhMGlSTG4wMkxvM2hrd2RJOW1LQXh2TGczYmdsc3VoQVFJMG1Say1odFdONTIyRGhNWThwZml4alQ5RVVpOGJZYXhmQzd3UFNNU29WZkd0YU1Ga3FnbFFFWU1WQ3FkN29PZDdYVHpBV0NuNzd2REU5S3lUdlRSQmpUeXVZWEx3Zw?oc=5","date":"2022-06-02","type":"pipeline","source":"prnewswire.com","summary":"Age-Related Macular Degeneration (AMD) Therapeutics Market Size to Grow by USD 7.92 billion | High Prevalence of AMD to Drive Growth | Technavio - prnewswire.com","headline":"Age-Related Macular Degeneration (AMD) Therapeutics Market Size to Grow by USD 7.92 billion | High Prevalence of AMD to ","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMizgFBVV95cUxNU0ZOOVExTGd5WmVWVHhrNjNZajRqMFJlemVGdmlqcUJOMjJ6aldmRUZ5WnZjSW9tM3k2SXhYdjU5R0VFN1hpckdqYmJEZXlKY3V3Tks2MGZCZV9hZlJ4dDlHSXV5cWY5R21TX1BJcmFPSVE2SmVTcGVZcUVWWjQwSk5TQWtEdk5OTjdIUGx2QXVDRFpkaXlBck5ReEk4R2xId1J3elFLUlNTTm5TNkVxQnJfY2ZRdjV4X1Z4bDU4YTlOcENacGlrZ3cwMkhFZw?oc=5","date":"2021-06-22","type":"pipeline","source":"businesswire.com","summary":"William J. Link, PhD, Named Chairman of Allegro Ophthalmics’ Board of Directors - businesswire.com","headline":"William J. Link, PhD, Named Chairman of Allegro Ophthalmics’ Board of Directors","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":0,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}